Literature DB >> 33705578

Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value.

Christopher J Black1,2, Yan Yiannakou3, Elspeth Guthrie4, Robert West4, Lesley A Houghton1, Alexander C Ford1,2.   

Abstract

BACKGROUND: Conventionally, irritable bowel syndrome (IBS) is subgrouped using predominant stool form, yet it is a complex disorder, with multiple biopsychosocial contributors. We previously derived and validated a latent class model subgrouping people with IBS into seven clusters based on gastrointestinal and extraintestinal symptoms and psychological profile. AIMS: To conduct longitudinal follow-up examining the natural history and prognostic value of these clusters.
METHODS: Participants completed a 12-month follow-up questionnaire. We applied our model to these data, comparing cluster membership between the two time points in those still meeting Rome IV criteria at follow-up, including stratifying the analysis by predominant stool pattern, and level of psychological burden, at baseline. We examined whether baseline cluster predicted the course of IBS, and whether starting new treatment was associated with changing cluster.
RESULTS: Eight hundred and eleven participants met Rome IV criteria for IBS at baseline, of whom 452 (55.7%) responded, and 319 (70.6%) still met Rome IV criteria for IBS at follow-up. Of these, 172 (53.9%) remained in the same IBS cluster as at baseline and 147 changed cluster. Cluster membership stratified according to psychological comorbidity was more stable; 84% of those in a cluster with high psychological burden at baseline remained in such a cluster at follow-up. People in clusters with high psychological burden at baseline had more severe symptoms (P < 0.001), received a higher mean number of subsequent treatments (P < 0.001), and were more likely to consult a doctor than people in clusters with low psychological burden (P < 0.001). There was no significant association between starting a new treatment and changing cluster at follow-up.
CONCLUSIONS: Longitudinal follow-up demonstrated little transition between clusters with respect to psychological burden, and these appeared to predict disease course. Directing treatment according to cluster, including earlier use of psychological therapies, and exploring how this approach influences outcomes in IBS, should be examined.
© 2021 John Wiley & Sons Ltd.

Entities:  

Year:  2021        PMID: 33705578     DOI: 10.1111/apt.16322

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  5 in total

1.  Defining the irritable bowel.

Authors:  Kee Huat Chuah; Sanjiv Mahadeva
Journal:  JGH Open       Date:  2022-04-20

2.  The symptom burden of Irritable Bowel Syndrome in tertiary care during the COVID-19 pandemic.

Authors:  Hithin Noble; Syed Shariq Hasan; Peter J Whorwell; Dipesh H Vasant
Journal:  Neurogastroenterol Motil       Date:  2022-03-03       Impact factor: 3.960

Review 3.  Extraintestinal manifestations in irritable bowel syndrome: A systematic review.

Authors:  Bodil Ohlsson
Journal:  Therap Adv Gastroenterol       Date:  2022-08-09       Impact factor: 4.802

4.  Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study.

Authors:  Kathleen Van Malderen; Nikita Hanning; Helen Lambrechts; Tine Haverhals; Silke Van Marcke; Hannah Ceuleers; Joris G De Man; Benedicte Y De Winter; Kevin Lamote; Heiko U De Schepper
Journal:  Front Med (Lausanne)       Date:  2022-08-04

5.  Impact of Rome IV irritable bowel syndrome on work and activities of daily living.

Authors:  Vivek C Goodoory; Cho Ee Ng; Christopher J Black; Alexander C Ford
Journal:  Aliment Pharmacol Ther       Date:  2022-07-06       Impact factor: 9.524

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.